Recent discoveries of pharmacological modulators of kinase activity (Simpson et al, 2009; Ferguson & Gray, 2018), open the possibility of developing candidate tools to better increase our understanding of the mechanisms involved in modulating HTT phosphorylation and their contribution to HD pathophysiology. The gene discussed is HTT; the disease is Huntington disease.